IP Verse

Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular Risk

Patent No. EP3270909 (titled "Fixed Dose Combinations Comprising Etc1002 And One Or More Statins For Treating Or Reducing Cardiovascular Risk") was filed by Esperion Therapeutics on Mar 16, 2016. The application was issued on Nov 1, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions (6)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
INTAS PHARMACEUTICALSAug 1, 2024BRAND MURRAY FULLER
GALENICUM HEALTH SLUJul 31, 2024GALENICUM HEALTH SLU
HOEFER & PARTNER PATENTANWALTE MBBJul 31, 2024HOEFER & PARTNER PATENTANWALTE MBB
POLPHARMAJul 31, 2024HAMM & WITTKOPP
SYNTHONJul 30, 2024REDDIE & GROSE
STADA ARZNEIMITTELJul 26, 2024HAMM & WITTKOPP

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3270909

ESPERION THERAPEUTICS
Application Number
EP16765682A
Filing Date
Mar 16, 2016
Status
Granted And Under Opposition
Sep 29, 2023
Publication Date
Nov 1, 2023
External Links
Slate, Register , Google Patents